RSG
62
2
PSX
39
4
ABT
60
-2
FAST
55
3
OI
29
4
CAT
62
3
HCA
50
4
BRK.B
38
4
LLY
25
-8
EXPD
20
-3
DTE
67
2
DHR
46
-4
MUR
30
-4
QCOM
55
2
EQR
39
-3
ETR
77
-2
EQIX
62
3
VFC
70
-2
ZTS
38
-2
PPL
62
2
RSG
62
2
PSX
39
4
ABT
60
-2
FAST
55
3
OI
29
4
CAT
62
3
HCA
50
4
BRK.B
38
4
LLY
25
-8
EXPD
20
-3
DTE
67
2
DHR
46
-4
MUR
30
-4
QCOM
55
2
EQR
39
-3
ETR
77
-2
EQIX
62
3
VFC
70
-2
ZTS
38
-2
PPL
62
2
Financhill
Back

Bio-Rad Laboratories 10K Form

Buy
56

BIO
Bio-Rad Laboratories

Last Price:
$342.96
Seasonality Move:
8.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO News And Ratings

See the #1 stock for the next 7 days that we like better than BIO

BIO Financial Statistics

Sales & Book Value

Annual Sales: $2.7B
Cash Flow: $100M
Price / Cash Flow: 43.5
Annual Sales: $267.46
Price / Book: 1.28

Profitability

EPS (TTM): -27.33000
Net Income (TTM): $-778.7M
Gross Margin: $1.4B
Return on Equity: -9.62%
Return on Assets: -6.82%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIO is 53.42%.
  • The Selling, General & Administrative Expenses for BIO have been equal to 31.51% of Gross Profit Margin.
  • The Research & Development expenses have been 9.26% of Revenue.
  • The Net Earning history of BIO is -23.86% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 27 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO
CUSIP: 090572
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 6.14
Quick Ratio: 4.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 26.89

BIO Technical Analysis vs Fundamental Analysis

Buy
56
Bio-Rad Laboratories (BIO) is a Buy

Is Bio-Rad Laboratories a Buy or a Sell?